journal article·2002Open access

Tumor-Promoting Activity of 48 kDa Molecular Mass Hyaluronic Acid

Jeong Ung Park, Toshie Tsuchiya

MATERIALS TRANSACTIONS· Volume 43· Issue 12

Abstract

Hyaluronic acid (HA), glycosaminoglycan, has long been implicated in malignant transformation and tumor-promoting activity. We found that 48 kDa molecular mass HA in vitro promotes tumor cell growth and tumorigenesis. The increase of cell growth rate in human hepatoma cells (HepG2 cells, cancer cells) and normal human dermal fibroblasts (NHDF cells, normal cells) treated with 48 kDa HA at 2×10−4 kg/L concentration were 110±0.9% and 103±0.5%, respectively. Colony formation activity of 4.8 kDa HA in cultured Balb/3T3 clone A3111 cells was higher than that of 48 kDa HA . However, transforming activity of HA was significantly showed in 48 kDa HA but not in 4.8 kDa HA . These findings suggest that 48 kDa HA has a tumor-promoting activity stronger than 4.8 kDa HA, because the former increase the cell growth of cancer cells than the latter. The increase of cell growth rate in HepG2 cells (cancer cells) and NHDF cells (normal cells) were compared among various molecular masses of HA.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Proteoglycans and glycosaminoglycans research · Glycosylation and Glycoproteins Research · Fibroblast Growth Factor Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Medical Devices, National Institute of Health Sciences

References (21)

Show source-provided references
1. 1) T. C. Laurent and J. R. Fraser: FASEB J. 6 (1992) 2397–2404.10.1096/fasebj.6.7.1563592 ↗
2. 2) J. L. Lapcik, L. Lapcik, S. D. Smedt, J. Demeester and P. Chabrecek: Chem. Rev. 98 (1998) 2663–2684.10.1021/cr941199z ↗
3. 3) R. Stern, S. Shuster, T. S. Wiley and B. Formby: Exp. Cell Res. 266 167–176.10.1006/excr.2001.5206 ↗
4. 4) V. B. Lokeshwar, D. Rubinowicz, G. L. Schroeder, E. Forgacs, J. D. Minna, N. L. Block, M. Nadji and B. L. Lokeshwar: J. Biol. Chem. 276 (2001) 11922–11932.10.1074/jbc.M008432200 ↗
5. 5) V. Assmann, J. F. Marshall, C. Fieber, M. Hofmann and I. R. Hart: J. Cell Sci. 111 (1998) 1685–1694.10.1242/jcs.111.12.1685 ↗
6. 6) J. Lesley, V. C. Hascall, M. Tammi and R. Hyman: J. Biol. Chem. 275 (2000) 26967–26975.10.1016/S0021-9258(19)61467-5 ↗
7. 7) L. Y. Bourguignon, H. Zhu, B. Zhou, F. Diedrich, P. A. Singleton and M. C. Hung: J. Biol. Chem. 276 (2001) 48679–48692.10.1074/jbc.M106759200 ↗
8. 8) N. Iida and L. Y. W. Bourguignon: J. Cell. Physiol. 171 (1997) 152–160.10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.0.CO;2-N ↗
9. 9) R. K. Chiu, A. Droll, S. T. Dougherty, C. Carpenito, D. L. Cooper and G. J. Dougherty: Exp. Cell Res. 248 (1999) 314–321.10.1006/excr.1999.4391 ↗
10. 10) J. A. Cramer, L. C. Bailey, C. A. Bailey and R. T. Miller: Biochim. Biophys. Acta. 1200 (1993) 315–321.10.1016/0304-4165(94)90173-2 ↗
11. 11) P. Goegan, G. Johnson and R. Vincent: Toxic In Vitro 9 (1995) 257–266.10.1016/0887-2333(95)00004-R ↗
12. 12) T. Tsuchiya, K. Fukuhara, H. Hata, Y. Ikarashi, N. Miyata, F. Katoh, H. Yamasaki and A. Nakamura: J. Biomed. Mater. Res. 29 (1995) 121–126.10.1002/jbm.820290117 ↗
13. 13) T. Tsuchiya, R. Nakaoka, H. Degawa and A. Nakamura: J. Biomed. Mater. Res. 31 (1996) 299–303.10.1002/(SICI)1097-4636(199607)31:3<299::AID-JBM2>3.0.CO;2-H ↗
14. 14) C. L. Shapiro, J. Keating, J. E. Angell, M. Janicek, R. Gelman, D. Hayes and M. S. LeBoff: Cancer Invest. 17 (1999) 566–574.10.3109/07357909909032841 ↗
15. 15) R. Kosaki, K. Watanabe and Y. Yamaguchi: Cancer Res. 59 (1999) 1141–1145.
16. 16) N. S. Chang, N. Pratt, J. Heath, L. Schultz, D. Sleve, G. B. Carey and N. Zevotek: J. Biol. Chem. 276 (2001) 3361–3370.10.1074/jbc.M007140200 ↗
17. 17) T. Asplund and P. Heldin: Cancer Res. 54 (1994) 4516–4523.
18. 18) M. Culty, M. Shizari, E. W. Thompson and C. B. Underhill: J. Cell Physiol. 160 (1994) 275–286.10.1002/jcp.1041600209 ↗
19. 19) D. J. Beech, A. K. Madan and N. Deng: J. Surg. Res. 103 (2002) 203–207.10.1006/jsre.2002.6351 ↗
20. 20) A. Thylen, J. Wallin and G. Martensson: Cancer. 86 (1999) 2000–2005.10.1002/(SICI)1097-0142(19991115)86:10<2000::AID-CNCR17>3.3.CO;2-E ↗
21. 21) K. Isama, A. Matsuoka, Y. Haishima and T. Tsuchiya: Mater. Trans. (2002) Accepted.